Editas Medicine
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.About EDIT
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9).
CEOGilmore O’Neill
CEOGilmore O’Neill
Employees246
Employees246
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2013
Founded2013
Employees246
Employees246
EDIT Key Statistics
Market cap231.36M
Market cap231.36M
Price-Earnings ratio-1.06
Price-Earnings ratio-1.06
Dividend yield—
Dividend yield—
Average volume1.72M
Average volume1.72M
High today$2.61
High today$2.61
Low today$2.34
Low today$2.34
Open price$2.49
Open price$2.49
Volume1.94M
Volume1.94M
52 Week high$4.54
52 Week high$4.54
52 Week low$0.9101
52 Week low$0.9101
Stock Snapshot
The current Editas Medicine(EDIT) stock price is $2.41, with a market capitalization of 231.36M. The stock trades at a price-to-earnings (P/E) ratio of -1.06.
During the trading session on 2025-12-17, Editas Medicine(EDIT) shares reached a daily high of $2.61 and a low of $2.34. At a current price of $2.41, the stock is +3.0% higher than the low and still -7.7% under the high.
Trading activity shows a volume of 1.94M, compared to an average daily volume of 1.72M.
Over the past 52 weeks, Editas Medicine(EDIT) stock has traded between a high of $4.54 and a low of $0.91.
Over the past 52 weeks, Editas Medicine(EDIT) stock has traded between a high of $4.54 and a low of $0.91.
Analyst ratings
47%
of 15 ratingsBuy
46.7%
Hold
40%
Sell
13.3%
People also own
Based on the portfolios of people who own EDIT. This list is generated using Robinhood data, and it’s not a recommendation.